Inovio Pharmaceuticals

Vital Pharmaceuticals

Hi-Tech Pharmaceuticals

Inovio Pharmaceuticals

Claims about the development of a coronavirus vaccine are at the center of a class-action lawsuit.

Supplements from Hi-Tech Pharmaceuticals

In November 2019, a class-action lawsuit was filed against Hi-Tech Pharmaceuticals for allegedly failing to disclose that supplements – including Ultimate Orange, HydroxyElite, Lipodrene Elite, Synadrene, and Jack’d Up –…

Hi-Tech Pharmaceuticals Garcinia Cambogia Extract

March 2015: A federal judge dismissed this lawsuit finding that the complaint did not sufficiently show that the $5 million amount-in-controversy requirement was met. September 2014: A class-action lawsuit was…

Pharmaceuticals Top the Spam List

Spam levels have dropped to a 3-year record low, reports security firm, Symantec, in their November 2011 Intelligence Report.  But before you start jumping up and down with excitement, keep…

Amberen

TINA.org investigated the marketing for Amberen, a menopause supplement brand owned and marketed by Alliance Pharmaceuticals, and found that it is deceptively promoted as “clinically proven” to provide menopause and…

A Growing List of Coronavirus Scams

A master list of known and alleged scams.

Makena

March 2020: The Gill case was transferred from a court in Kansas to a court in New Jersey. (Case No. 20-cv-3230, D.N.J.) February 2020: The Faughnan and Barnes cases were…

SnoreStop

October 2017: A California appellate court reversed the trial court decision finding that plaintiffs did present enough evidence to support their claims, and directed the trial court to enter a…

The Menopause Deception Epidemic

How the supplement industry is taking advantage of women and what TINA.org is doing to fight it.

Proactiv

Allegations: Misleadingly representing that products were safe when they contained, or were at risk of containing, the carcinogen benzene

CeraVe Baby Sunscreen

May 2017: This action was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. March 2017: A class-action…

Study Calls on FDA to Act on Stimulant Found in Weight-Loss Products

Amphetamine-like ingredient found in Acacia rigidula dietary supplements could trigger harmful reactions.

FDA Warns Companies about Dangers of Stimulants in Supplements

Eight products found to have BMPEA and 17 products contain DMBA, both amphetamine-like stimulants.

Wyeth Agrees to $490 Million Payout for Unlawful Marketing

Justice Department says company put profits over safety.

Coronavirus Spawns Class-Action Lawsuits as Consumers Seek Refunds

The pandemic has also triggered lawsuits over privacy issues with some video conferencing apps, and more.

Menopause Supplements

TINA.org investigated marketing tactics used by the menopause supplement industry and urged 100 companies to review their marketing.

Combivent Respimat Asthma Inhalers

In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs,…